1985 …2025

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Biography

Mark Cooper AO is Professor of Diabetes and head of the Department of Diabetes within the Central Clinical School. His research and clinical interests are in diabetes and its complications, including kidney disease, heart disease and blindness.

Biography

Research area keywords

  • Diabetes
  • Diabetic Complications
  • kidney disease
  • heart disease
  • blindness

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

Research Output

A physician-initiated double-blind, randomised, placebo-controlled, phase 2 study evaluating the efficacy and safety of inhibition of NADPH oxidase with the first-in-class Nox-1/4 inhibitor, GKT137831, in adults with type 1 diabetes and persistently elevated urinary albumin excretion: Protocol and statistical considerations

Reutens, A. T., Jandeleit-Dahm, K., Thomas, M., Salim, A., De Livera, A. M., Bach, L. A., Colman, P. G., Davis, T. M. E., Ekinci, E. I., Fulcher, G., Hamblin, P. S., Kotowicz, M. A., MacIsaac, R. J., Morbey, C., Simmons, D., Soldatos, G., Wittert, G., Wu, T., Cooper, M. E. & Shaw, J. E., Mar 2020, In : Contemporary Clinical Trials. 90, 8 p., 105892.

Research output: Contribution to journalArticleOtherpeer-review

1 Citation (Scopus)

Cardiovascular and kidney outcomes of linagliptin treatment in older people with type 2 diabetes and established cardiovascular disease and/or kidney disease: A prespecified subgroup analysis of the randomized, placebo-controlled CARMELINA® trial

Cooper, M. E., Rosenstock, J., Kadowaki, T., Seino, Y., Wanner, C., Schnaidt, S., Clark, D., Johansen, O. E. & on behalf of the CARMELINA investigators, 1 Feb 2020, (Accepted/In press) In : Diabetes, Obesity and Metabolism. 12 p.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
File
1 Citation (Scopus)

Complement C5a induces renal injury in diabetic kidney disease by disrupting mitochondrial metabolic agility

Tan, S. M., Ziemann, M., Thallas-Bonke, V., Snelson, M., Kumar, V., Laskowski, A., Nguyen, T. V., Huynh, K., Clarke, M. V., Libianto, R., Baker, S. T., Skene, A., Power, D. A., MacIsaac, R. J., Henstridge, D. C., Wetsel, R. A., El-Osta, A., Meikle, P. J., Wilson, S. G., Forbes, J. M. & 4 others, Cooper, M. E., Ekinci, E. I., Woodruff, T. M. & Coughlan, M. T., 1 Jan 2020, In : Diabetes. 69, 1, p. 83-98 16 p.

Research output: Contribution to journalArticleResearchpeer-review

1 Citation (Scopus)

Delineating a role for the mitochondrial permeability transition pore in diabetic kidney disease by targeting cyclophilin D

Lindblom, R. S. J., Higgins, G. C., Nguyen, T. V., Arnstein, M., Henstridge, D. C., Granata, C., Snelson, M., Thallas-Bonke, V., Cooper, M. E., Forbes, J. M. & Coughlan, M. T., 29 Jan 2020, In : Clinical Science. 134, 2, p. 239-259 21 p.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
File
1 Citation (Scopus)

Glucose and Blood Pressure-Dependent Pathways-The Progression of Diabetic Kidney Disease

Patel, D. M., Bose, M. & Cooper, M. E., 23 Mar 2020, In : International Journal of Molecular Sciences. 21, 6, 32 p., 2218.

Research output: Contribution to journalReview ArticleResearchpeer-review

Open Access
File